N/A
Completed N=207
mHealth Intervention to Support Diabetes Medication Adherence (Pilot Study)
Source: ClinicalTrials.gov NCT04738591 ↗Enrolled (actual)
207
Serious AEs
—
Results posted
Feb 2025
Primary outcomePrimary: Glycated Hemoglobin (HbA1C) — 9; 9.1; 7.7; 7.6 Percentage of HbA1c
Summary
This study aims at evaluating the feasibility of an intervention based on the use of a mobile-device based system delivering automated, tailored brief text messages to offer support for medicine use and lifestyle recommendations alongside usual care to people with type 2 diabetes.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Glycated Hemoglobin (HbA1C) |
9; 9.1; 7.7; 7.6 | — |
| SECONDARY Number of Participants Classified as Adherent Based on Self-reporteAdherence to Antidiabetic Medication (7 Items ad Hoc Questionnaire) |
72; 76; 73; 62 | — |
| SECONDARY Enrolment or Recruitment Rate |
207 | — |
| SECONDARY Retention Rate |
89; 90 | — |
Eligibility Criteria
Inclusion Criteria
- Patients registered in the Public Health Service of the Balearic Islands
- With type 2 diabetes
- At least one prescription of an oral glucose-lowering drug
- With results of HbA1C>8% from 3 months prior to recruitment.
Exclusion Criteria
- Younger than 18 years old
- With insulin treatment.
Data sourced from ClinicalTrials.gov (NCT04738591). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.